Reference : Rimonabant as an adjunct therapy in overweight/obese patients with type 2 diabetes.
Scientific journals : Article
Human health sciences : Endocrinology, metabolism & nutrition
http://hdl.handle.net/2268/8991
Rimonabant as an adjunct therapy in overweight/obese patients with type 2 diabetes.
English
Scheen, André mailto [Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
Van Gaal, Luc F [> > > >]
2007
European Heart Journal
28
11
1401-2; author reply 1402
Yes (verified by ORBi)
0195-668X
England
[en] Chemotherapy, Adjuvant ; Diabetes Mellitus, Type 2/drug therapy ; Humans ; Hypoglycemic Agents/therapeutic use ; Obesity/complications ; Piperidines/therapeutic use ; Pyrazoles/therapeutic use
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/8991
10.1093/eurheartj/ehm123
The original article can be found at http://eurheartj.oxfordjournals.org/content/vol28/issue11/index.dtl#LETTERS_TO_THE_EDITOR

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Rimonabant as an adjunct therapy_ocr.pdfNo commentaryAuthor postprint17.96 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.